Combined modality therapy in the adjuvant treatment of uterine serous carcinoma.
作者信息
Block Alec M, Small William
机构信息
Department of Radiation Oncology, Loyola University, Chicago, IL, USA.
出版信息
J Gynecol Oncol. 2016 Mar;27(2):e13. doi: 10.3802/jgo.2016.27.e13.
Abstract
摘要
相似文献
1
Combined modality therapy in the adjuvant treatment of uterine serous carcinoma.联合模式疗法在子宫浆液性癌辅助治疗中的应用
J Gynecol Oncol. 2016 Mar;27(2):e13. doi: 10.3802/jgo.2016.27.e13.
2
Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?辅助治疗对IA期浆液性和透明细胞子宫癌的作用：观察等待是否是一种有效的策略？
Int J Gynecol Cancer. 2016 Mar;26(3):491-6. doi: 10.1097/IGC.0000000000000643.
3
Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.化疗和放疗对早期子宫透明细胞癌和乳头状浆液性癌治疗的影响
Int J Gynecol Cancer. 2017 May;27(4):720-729. doi: 10.1097/IGC.0000000000000926.
4
Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study.辅助化疗和盆腔放疗对Ⅰ期非浸润性子宫乳头状浆液性癌复发模式及预后的影响：一项多机构研究
Gynecol Oncol. 2015 May;137(2):239-44. doi: 10.1016/j.ygyno.2015.01.544. Epub 2015 Jan 29.
5
Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma.早期子宫癌肉瘤与子宫浆液性癌结局的比较。
Gynecol Oncol. 2014 Oct;135(1):49-53. doi: 10.1016/j.ygyno.2014.07.097. Epub 2014 Jul 30.
6
[Uterine papillary serous carcinoma].
Orv Hetil. 2011 Jul 24;152(30):1206-8. doi: 10.1556/OH.2011.29157.
7
Uterine papillary serous carcinoma: patterns of failure and survival.子宫浆液性乳头状癌：复发模式与生存情况
Aust N Z J Obstet Gynaecol. 2009 Aug;49(4):419-25. doi: 10.1111/j.1479-828X.2009.01016.x.
8
Long-term survival in uterine clear cell carcinoma and uterine papillary serous carcinoma.子宫透明细胞癌和子宫乳头状浆液性癌的长期生存。
Anticancer Res. 2010 Sep;30(9):3727-30.
9
Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.接受辅助铂类化疗的手术I期子宫浆液性乳头状癌（UPSC）患者生存率提高。
Gynecol Oncol. 2005 Sep;98(3):353-9. doi: 10.1016/j.ygyno.2005.06.012.
10
Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).子宫浆液性乳头状癌综合治疗后的结局：罕见癌症网络（RCN）的一项研究
Gynecol Oncol. 2008 Feb;108(2):298-305. doi: 10.1016/j.ygyno.2007.10.037. Epub 2007 Dec 21.
引用本文的文献
1
Stage III uterine serous carcinoma: modern trends in multimodality treatment.III 期子宫浆液性癌：多模式治疗的现代趋势。
J Gynecol Oncol. 2020 Jul;31(4):e53. doi: 10.3802/jgo.2020.31.e53. Epub 2020 Feb 17.
本文引用的文献
1
The impact of combined radiation and chemotherapy on outcome in uterine papillary serous carcinoma compared to chemotherapy alone.与单纯化疗相比，联合放疗与化疗对子宫浆液性乳头状癌预后的影响。
J Gynecol Oncol. 2016 Mar;27(2):e19. doi: 10.3802/jgo.2016.27.e19. Epub 2015 Oct 12.
2
Phase II trial of adjuvant pelvic radiation "sandwiched" between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma.紫杉醇联合卡铂辅助盆腔放疗治疗子宫乳头状浆液性癌的 II 期临床试验。
Gynecol Oncol. 2012 Jan;124(1):21-5. doi: 10.1016/j.ygyno.2011.10.007. Epub 2011 Oct 27.
3
The importance of chemotherapy and radiation in uterine papillary serous carcinoma.化疗和放疗在子宫乳头状浆液性癌中的重要性。
Gynecol Oncol. 2011 Dec;123(3):542-7. doi: 10.1016/j.ygyno.2011.09.005. Epub 2011 Oct 2.
4
Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies.序贯辅助化疗和放疗治疗子宫内膜癌——两项随机研究结果。
Eur J Cancer. 2010 Sep;46(13):2422-31. doi: 10.1016/j.ejca.2010.06.002. Epub 2010 Jul 7.
5
Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.含铂/紫杉烷类化疗联合或不联合放射治疗对Ⅰ期子宫浆液性乳头状癌的生存结局有积极影响。
Cancer. 2009 May 15;115(10):2119-27. doi: 10.1002/cncr.24247.
6
Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma.子宫浆液性乳头状癌：子宫内膜腺癌的一种高度恶性形式。
Am J Surg Pathol. 1982 Mar;6(2):93-108. doi: 10.1097/00000478-198203000-00002.
Zotero 插件